Umbilical and menstrual stem cells to offer more therapies?
Tuesday 8th March 2011
Stem cells harvested from umbilical cord blood and menstrual blood could offer new therapies for conditions such as Alzheimer's disease, stroke and amyotrophic lateral sclerosis, research has indicated.
A study published in Cell Transplantation suggested that these cells would be used to promote cell survival rather than act as replacements when transplanted.
This is due to the immunological immaturity of the cells and their ability to differentiate into different types of cells.
The study pointed out the convenience of using these cells as they could be gathered at the time of birth as well as every month from women.
Meanwhile, research conducted at the Children's Hospital of Philadelphia found that blood retains its clotting properties for at least 11 days using standard refrigeration.
This is far longer than the current shelf life of 24 to 48 hours.
Written by Angela Newbury
Related articles
Chemical to tackle breast cancer found in celery
Doctors and those in biomedical science jobs have long been searching for a definitive treatment to help treat breast cancer, but...
Thursday 17th May 2012
Prostate cancer drug set to be approved
A prostate cancer drug is set to be approved and put into use across NHS services after previously being rejected. The...
Wednesday 16th May 2012
Blindness could be treated with diabetes drug
Blindness is one condition that many people fear, the debilitating effect that it has can change a person's life forever. ...
Wednesday 9th May 2012
Related Biomedical-Science Jobs
Job Title: BMS Histologist Job City of London Brief Details Experienced Histologist BMS needed for a on going permanant...
Full infoOur client is seeking a HPC Biomedical Scientist - Haematology We are looking for a HPC Registered Biomedical Scientist for a locum...
Full infoLondon based Biomedical Scientist required!As a preferred supplier to the London Procurement Programme (LPP) represented...
Full info